Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

01. Mai 2024 14:17 ET | Quelle: Spherix Global Insights

Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Market

EXTON, PA, May 01, 2024 (GLOBE NEWSWIRE) -- In the landscape of healthcare innovation, retinal disorders, including both inherited and degenerative diseases, have become a leading focus area for...
17. August 2023 07:30 ET | Quelle: Transparency Market Research

Macular Degeneration Treatment Market to Expand USD 21.1 Bn by 2031, Registering at a CAGR of 8.8% | Exclusive Report by Transparency Market Research

Wilmington, Delaware, United States, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global macular degeneration treatment market is projected to exceed US$ 21.1 Bn by...
16. November 2022 13:30 ET | Quelle: Transparency Market Research

Ophthalmic Drugs Market to Develop at CAGR of 6.83% during Forecast Period: TMR Study

Wilmington, Delaware, United States, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - In 2021, the value of the ophthalmic drugs market stood at US$ 26.46 Bn. Analysis of...
21. November 2019 08:00 ET | Quelle: Amarantus Bioscience Holdings, Inc.

Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorders for Subsidiary MANF Therapeutics

Patent covers use of MANF in Glaucoma, Wolfram Syndrome and Retinitis Pigmentosa New York, NY, Nov. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amarantus Bioscience Holdings, Inc. (OTC...